Abstract

Methodology for sequence analysis of ∼150 kDa monoclonal antibodies (mAb), including location of post-translational modifications and disulfide bonds, is described. Limited digestion of fully denatured (reduced and alkylated) antibody was accomplished in seconds by flowing a sample in 8murea at a controlled flow rate through a micro column reactor containing immobilized aspergillopepsin I. The resulting product mixture containing 3-9 kDa peptides was then fractionated by capillary column liquid chromatography and analyzed on-line by both electron-transfer dissociation and collisionally activated dissociation mass spectrometry (MS). This approach enabled identification of peptides that cover the complete sequence of a murine mAb. With customized tandem MS and ProSightPC Biomarker search, we verified 95% amino acid residues of this mAb and identified numerous post-translational modifications (oxidized methionine, pyroglutamylation, deamidation of Asn, and several forms ofN-linked glycosylation). For disulfide bond location, native mAb is subjected to the same procedure but with longer digestion times controlled by sample flow rate through the micro column reactor. Release of disulfide containing peptides from accessible regions of the folded antibody occurs with short digestion times. Release of those in the interior of the molecule requires longer digestion times. The identity of two peptides connected by a disulfide bond is determined using a combination of electron-transfer dissociation and ion-ion proton transfer chemistry to read the two N-terminal and two C-terminal sequences of the connected peptides.

Highlights

  • Typical mass spectrometry (MS) characterization of proteins uses a “BottomUp” approach

  • Time-controlled on-column digestion with aspergillopepsin I of the reduced, alkylated monoclonal antibodies (mAb) in 8 M urea narrows the size of major peptides to 3–9 kDa

  • Peptides in this MW range have higher sequence coverage compared with small tryptic peptides, and are spread across a wide range in the chromatogram generated from porous shell-type C18 silica particles

Read more

Summary

Technological Innovation and Resources

Analysis of Monoclonal Antibody Sequence and Post-translational Modifications by Time-controlled Proteolysis and Tandem Mass Spectrometry*□S. The resulting product mixture containing 3–9 kDa peptides was fractionated by capillary column liquid chromatography and analyzed on-line by both electron-transfer dissociation and collisionally activated dissociation mass spectrometry (MS) This approach enabled identification of peptides that cover the complete sequence of a murine mAb. With customized tandem MS and ProSightPC Biomarker search, we verified 95% amino acid residues of this mAb and identified numerous posttranslational modifications (oxidized methionine, pyroglutamylation, deamidation of Asn, and several forms of Nlinked glycosylation). Monoclonal antibodies (mAbs) and related biological molecules constitute one of the most rapidly growing classes of human therapeutics These large proteins (Fig. 1) have molecular weights near 150 kDa and are composed of two identical ϳ50 kDa heavy chains (HC) and two identical ϳ25 kDa light chains (LC) [1].

Comprehensive Characterization of Monoclonal Antibody
EXPERIMENTAL PROCEDURES
RESULTS
Met oxidation
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call